Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Bailey Downs, Lora C ^a   Thorpe, Jessica E ^a,b   Disch, Bryan C ^a   Bastian, Anja ^b   Hauser, Paul J ^a,c   Farasyn, Taleah ^a   Berry, William L ^c   Hurst, Robert E ^a,c   Ihnat, Michael A ^a,b  

^a DormaTarg Inc   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; FEMALE; LUNG METASTASIS; LUNG MICROMETASTASIS; MACROMETASTASIS; MALIGNANT TRANSFORMATION; METASTASIS; MICROMETASTASIS; MOUSE; NONHUMAN; PRIMARY TUMOR; TRIPLE NEGATIVE BREAST CANCER; TUMOR VOLUME; ANIMAL; BAGG ALBINO MOUSE; BREAST NEOPLASMS; DISEASE COURSE; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASM METASTASIS; NEOPLASM MICROMETASTASIS; PATHOLOGY; SECONDARY; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; DOXORUBICIN; FEMALE; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOPLASM MICROMETASTASIS;

EID: 84902326794     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098624     Document Type: Article

References (52)

1. Weigelt B, Peterse JL, van't Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5: 591-602. doi:10.1038/nrc1670. (Pubitemid 41081385)
2. Nkrumah FK, Perkins IV (1976) Relapse in Burkitt's lymphoma. Int J Cancer 17: 455-460.
3. Yuhas JM, Toya RE, Wagner E (1975) Specific and nonspecific stimulation of resistance to the growth and metastasis of the line 1 lung carcinoma. Cancer Res 35: 242-244.
4. Clayton F, Hopkins CL (1993) Pathologic correlates of prognosis in lymph node-positive breast carcinomas. Cancer 71: 1780-1790. (Pubitemid 23067394)
5. Naumov GN, Townson JL, MacDonald IC, Wilson SM, Bramwell VHC, et al. (2003) Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat 82: 199-206. doi:10.1023/B:BREA.0000004377.12288.3c. (Pubitemid 37521976)
6. Mittempergher L, Saghatchian M, Wolf DM, Michiels S, Canisius S, et al. (2013) A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences. Molecular Oncology: 1-13. doi:10.1016/j.molonc.2013.07.006.
7. Nishikawa S, Dewi DL, Ishii H, Konno M, Haraguchi N, et al. (2012) Transcriptomic study of dormant gastrointestinal cancer stem cells. Int J Oncol 41: 979-984. doi:10.3892/ijo.2012.1531.
8. Francia G, Cruz-Munoz W, Man S, Xu P, Kerbel RS (2011) Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat Rev Cancer 11: 135-141. doi:10.1038/nrc3001.
9. Viney JL (1995) Transgenic and gene knockout mice in cancer research. Cancer Metastasis Rev 14: 77-90.
10. Grippo PJ, Sandgren EP (2000) Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model. The American Journal of Pathology 157: 805-813. doi:10.1016/S0002-9440(10)64594-4. (Pubitemid 32109373)
11. Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, et al. (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res 56: 4096-4102. (Pubitemid 26304996)
12. Webster MA, Muller WJ (1994) Mammary tumorigenesis and metastasis in transgenic mice. Semin Cancer Biol 5: 69-76. (Pubitemid 124006637)
13. Hanahan D, Weinberg RA (2011) Hallmarks of Cancer: The Next Generation. Cell 144: 646-674. doi:10.1016/j.cell.2011.02.013.
14. Pulaski BA, Ostrand-Rosenberg S (2001) Mouse 4T1 breast tumor model. Curr Protoc Immunol Chapter 20: Unit20.2. doi:10.1002/0471142735.im2002s39.
15. Ihnat MA, Nervi AM, Anthony SP, Kaltreider RC, Warren AJ, et al. (1999) Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice. Oncol Res 11: 303-310.
16. Chow KS, Jun D, Helm KM, Wagner DH, Majka SM (2011) Isolation & characterization of Hoechst(low) CD45(negative) mouse lung mesenchymal stem cells. J Vis Exp: e3159. doi:10.3791/3159.
17. Erin N, Boyer PJ, Bonneau RH, Clawson GA, Welch DR (2004) Capsaicin-mediated denervation of sensory neurons promotes mammary tumor metastasis to lung and heart. Anticancer Res 24: 1003-1009. (Pubitemid 38625051)
18. Wenzel J, Zeisig R, Fichtner I (2010) Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions. Clin Exp Metastasis 27: 25-34. doi:10.1007/s10585-009-9299-y.
19. Burnet M (1957) Cancer; a biological approach. I. The processes of control. Br Med J 1: 779-786.
20. Toh B, Chew V, Dai X, Khoo K, Tham M, et al. (2012) Immune predictors of cancer progression. Immunol Res 53: 229-234. doi:10.1007/s12026-012-8288-4.
21. Hao N-B, Lü M-H, Fan Y-H, Cao Y-L, Zhang Z-R, et al. (2012) Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012: 948098. doi:10.1155/2012/948098.
22. Marabelle A, Kohrt H, Sagiv-Barfi I, Ajami B, Axtell RC, et al. (2013) Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. J Clin Invest 123: 2447-2463. doi:10.1172/JCI64859DS1.
23. Mahoney KH, Miller BE, Heppner GH (1985) FACS quantitation of leucine aminopeptidase and acid phosphatase on tumor-associated macrophages from metastatic and nonmetastatic mouse mammary tumors. J Leukoc Biol 38: 573-585. (Pubitemid 16244224)
24. Sawant A, Hensel JA, Chanda D, Harris BA, Siegal GP, et al. (2012) Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells. J Immunol 189: 4258-4265. doi:10.4049/jimmunol.1101855.
25. Pollack VA, Fidler IJ (1982) Use of young nude mice for selection of subpopulations of cells with increased metastatic potential from nonsyngeneic neoplasms. J Natl Cancer Inst 69: 137-141. (Pubitemid 12052391)
26. Melchior SW, Corey E, Ellis WJ, Ross AA, Layton TJ, et al. (1997) Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. Clin Cancer Res 3: 249-256. (Pubitemid 27107302)
27. D'Amato R, Wesolowski E, Smith LE (1993) Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse. Microvasc Res 46: 135-142. doi:10.1006/mvre.1993.1042.
28. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, et al. (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. The American Journal of Pathology 153: 865-873. doi:10.1016/S0002-9440(10)65628-3. (Pubitemid 28419039)
29. Almog N (2006) Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis. The FASEB Journal 20: 947-949. doi:10.1096/fj.05-3946fje.
30. Al-Sahaf O, Wang JH, Browne TJ, Cotter TG, Redmond HP (2010) Surgical injury enhances the expression of genes that mediate breast cancer metastasis to the lung. Ann Surg 252: 1037-1043. doi:10.1097/SLA.0b013e3181efc635.
31. Barkan D, Touny El LH, Michalowski AM, Smith JA, Chu I, et al. (2010) Metastatic Growth from Dormant Cells Induced by a Col-I-Enriched Fibrotic Environment. Cancer Res 70: 5706-5716. doi:10.1158/0008-5472. CAN-09-2356.
32. Gimbrone MA, Leapman SB, Cotran RS, Folkman J (1972) Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136: 261-276.
33. Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, et al. (2004) MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431: 1112-1117. doi:10.1038/nature03043. (Pubitemid 39472236)
34. Heppner GH, Dexter DL, DeNucci T, Miller FR, Calabresi P (1978) Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor. Cancer Res 38: 3758-3763. (Pubitemid 9045202)
35. Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52: 1399-1405.
36. Pulaski BA, Ostrand-Rosenberg S (1998) Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res 58: 1486-1493. (Pubitemid 28193612)
37. Lelekakis M, Moseley JM, Martin TJ, Hards D, Williams E, et al. (1999) A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis 17: 163-170. (Pubitemid 29335443)
38. Muraoka RS, Dumont N, Ritter CA, Dugger TC, Brantley DM, et al. (2002) Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J Clin Invest 109: 1551-1559. doi:10.1172/JCI15234. (Pubitemid 34663517)
39. Connolly EM, Harmey JH, O'Grady T, Foley D, Roche-Nagle G, et al. (2002) Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer. British Journal of Cancer 87: 231-237. doi:10.1038/sj.bjc.6600462.
40. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939. doi:10.1016/j.cell.2004.06.006. (Pubitemid 38798858)
41. Hiraga T, Williams PJ, Ueda A, Tamura D, Yoneda T (2004) Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model. Clin Cancer Res 10: 4559-4567. doi:10.1158/1078-0432. CCR-03-0325.
42. Smith MCP, Luker KE, Garbow JR, Prior JL, Jackson E, et al. (2004) CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64: 8604-8612. doi:10.1158/0008-5472. CAN-04-1844.
43. Bausero MA, Page DT, Osinaga E, Asea A (2004) Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis. Tumour Biol 25: 243-251. doi:10.1159/000081387. (Pubitemid 40082326)
44. Lirdprapamongkol K, Sakurai H, Kawasaki N, Choo M-K, Saitoh Y, et al. (2005) Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells. Eur J Pharm Sci 25: 57-65. doi:10.1016/j.ejps.2005.01.015. (Pubitemid 40602196)
45. Samant RS, Debies MT, Hurst DR, Moore BP, Shevde LA, et al. (2006) Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1). Cancer Lett 235: 260-265. doi:10.1016/j.canlet.2005.04.032.
46. Nam J-S, Suchar AM, Kang M-J, Stuelten CH, Tang B, et al. (2006) Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer. Cancer Res 66: 6327-6335. doi:10.1158/0008-5472. CAN-06-0068.
47. Heimburg J, Yan J, Morey S, Glinskii OV, Huxley VH, et al. (2006) Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11. Neoplasia 8: 939-948. doi:10.1593/neo. 06493. (Pubitemid 44706244)
48. Li H, Dutuor A, Fu X, Zhang X (2007) Induction of strong antitumor immunity by an HSV-2-based oncolytic virus in a murine mammary tumor model. J Gene Med 9: 161-169. doi:10.1002/jgm.1005. (Pubitemid 46523534)
49. Tao K, Fang M, Alroy J, Sahagian GG (2008) Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 8: 228. doi:10.1186/1471-2407-8- 228.
50. Roy Das L, Pathangey LB, Tinder TL, Schettini JL, Gruber HE, et al. (2009) Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast Cancer Res 11: R56. doi:10.1186/bcr2345.
51. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, et al. (2010) Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 28: 341-347. doi:10.1038/nbt.1618.
52. Kim EJ, Choi M-R, Park H, Kim M, Hong JE, et al. (2011) Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice. Breast Cancer Res 13: R78. doi:10.1186/bcr2927.